1 follower
Dyve is a clinical-stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout.
Industries
Headquarters
Stage
Employees
Links
5 members
3 members
2 members
Bio-Rad Laboratories
11 followers
BioMarin Pharmaceutical
21 followers
Adaptive Biotechnologies
Agilent Technologies
60 followers
Regeneron
77 followers
Discover companies
